A detailed history of Virginia Wealth Management Group, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Virginia Wealth Management Group, Inc. holds 6,515 shares of ABT stock, worth $729,223. This represents 0.47% of its overall portfolio holdings.

Number of Shares
6,515
Previous 6,485 0.46%
Holding current value
$729,223
Previous $673,000 10.25%
% of portfolio
0.47%
Previous 0.55%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$100.07 - $118.13 $3,002 - $3,543
30 Added 0.46%
6,515 $742,000
Q2 2024

Jul 16, 2024

BUY
$100.73 - $112.44 $201 - $224
2 Added 0.03%
6,485 $673,000
Q1 2024

Apr 25, 2024

SELL
$109.52 - $120.96 $78,744 - $86,970
-719 Reduced 9.98%
6,483 $736,000
Q4 2023

Feb 08, 2024

SELL
$90.19 - $110.4 $794,664 - $972,734
-8,811 Reduced 55.02%
7,202 $792,000
Q3 2023

Nov 03, 2023

BUY
$95.53 - $114.62 $8,979 - $10,774
94 Added 0.59%
16,013 $1.55 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $806 - $898
8 Added 0.05%
15,919 $1.74 Million
Q1 2023

May 05, 2023

BUY
$96.86 - $114.01 $17,725 - $20,863
183 Added 1.16%
15,911 $1.61 Million
Q4 2022

Feb 07, 2023

BUY
$95.06 - $111.52 $95 - $111
1 Added 0.01%
15,728 $1.73 Million
Q3 2022

Oct 19, 2022

SELL
$96.76 - $112.03 $5,805 - $6,721
-60 Reduced 0.38%
15,727 $1.52 Million
Q2 2022

Jan 04, 2023

SELL
$102.07 - $123.37 $840,546 - $1.02 Million
-8,235 Reduced 52.36%
7,492 $814,000
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $385,008 - $465,351
3,772 Added 31.39%
15,787 $1.72 Million
Q1 2022

Apr 20, 2022

SELL
$114.02 - $139.04 $6,385 - $7,786
-56 Reduced 0.46%
12,015 $1.47 Million
Q4 2021

Jan 18, 2022

BUY
$115.53 - $141.46 $1.39 Million - $1.71 Million
12,071 New
12,071 $1.7 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $196B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Virginia Wealth Management Group, Inc. Portfolio

Follow Virginia Wealth Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Wealth Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Virginia Wealth Management Group, Inc. with notifications on news.